Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder
- PMID:17316796
- DOI: 10.1016/j.neubiorev.2006.12.002
Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder
Abstract
Several models of attention-deficit hyperactivity disorder (ADHD) have been proposed, ranging from administration of neurotoxins to genetically manipulated models. These models are used to gain insight into ADHD as a disorder and assist in the discovery of new therapeutic strategies. However, the information gained from these models differs, depending to a large extent on the validity (or otherwise) of the model. Thus the insights gained from these models with respect to the pathophysiology and aetiology of ADHD remains inconclusive. No animal model resembles the clinical situation of ADHD perfectly but good animal models of ADHD should mimic its characteristics, confirm to an underlying theory of ADHD and ultimately make predictions of future therapies. While the involvement of dopamine (DA) in ADHD has been established, the evaluation of rodent models of ADHD particularly with respect to dopaminergic systems is attempted here. It is concluded that the neonatal 6-hydroxy-dopamine lesioned rat and DA transporter knockout/knockdown mice have the highest degree of validity for ADHD.
Similar articles
- Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).Oades RD.Oades RD.Prog Brain Res. 2008;172:543-65. doi: 10.1016/S0079-6123(08)00926-6.Prog Brain Res. 2008.PMID:18772050Review.
- Strengths and limitations of genetic models of ADHD.Gainetdinov RR.Gainetdinov RR.Atten Defic Hyperact Disord. 2010 Mar;2(1):21-30. doi: 10.1007/s12402-010-0021-3. Epub 2010 Mar 6.Atten Defic Hyperact Disord. 2010.PMID:21432587Review.
- The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.Avale ME, Falzone TL, Gelman DM, Low MJ, Grandy DK, Rubinstein M.Avale ME, et al.Mol Psychiatry. 2004 Jul;9(7):718-26. doi: 10.1038/sj.mp.4001474.Mol Psychiatry. 2004.PMID:14699433
- Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses.Genro JP, Kieling C, Rohde LA, Hutz MH.Genro JP, et al.Expert Rev Neurother. 2010 Apr;10(4):587-601. doi: 10.1586/ern.10.17.Expert Rev Neurother. 2010.PMID:20367210Review.
- The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles.Oades RD, Sadile AG, Sagvolden T, Viggiano D, Zuddas A, Devoto P, Aase H, Johansen EB, Ruocco LA, Russell VA.Oades RD, et al.Dev Sci. 2005 Mar;8(2):122-31. doi: 10.1111/j.1467-7687.2005.00399.x.Dev Sci. 2005.PMID:15720370Review.
Cited by
- Sex Differences in Long-term Outcome of Prenatal Exposure to Excess Glucocorticoids-Implications for Development of Psychiatric Disorders.Elberling F, Spulber S, Bose R, Keung HY, Ahola V, Zheng Z, Ceccatelli S.Elberling F, et al.Mol Neurobiol. 2023 Dec;60(12):7346-7361. doi: 10.1007/s12035-023-03522-5. Epub 2023 Aug 10.Mol Neurobiol. 2023.PMID:37561236Free PMC article.
- Semi-Automated Biomarker Discovery from Pharmacodynamic Effects on EEG in ADHD Rodent Models.Yokota T, Struzik ZR, Jurica P, Horiuchi M, Hiroyama S, Li J, Takahara Y, Ogawa K, Nishitomi K, Hasegawa M, Cichocki A.Yokota T, et al.Sci Rep. 2018 Mar 26;8(1):5202. doi: 10.1038/s41598-018-23450-y.Sci Rep. 2018.PMID:29581452Free PMC article.
- Response requirement and increases in accuracy produced by stimulant drugs in a 5-choice serial reaction-time task in rats.Koffarnus MN, Katz JL.Koffarnus MN, et al.Psychopharmacology (Berl). 2011 Feb;213(4):723-33. doi: 10.1007/s00213-010-2027-0. Epub 2010 Oct 6.Psychopharmacology (Berl). 2011.PMID:20924752Free PMC article.
- A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men.Perry W, Minassian A, Paulus MP, Young JW, Kincaid MJ, Ferguson EJ, Henry BL, Zhuang X, Masten VL, Sharp RF, Geyer MA.Perry W, et al.Arch Gen Psychiatry. 2009 Oct;66(10):1072-80. doi: 10.1001/archgenpsychiatry.2009.58.Arch Gen Psychiatry. 2009.PMID:19805697Free PMC article.
- Focusing on symptoms rather than diagnoses in brain dysfunction: conscious and nonconscious expression in impulsiveness and decision-making.Palomo T, Beninger RJ, Kostrzewa RM, Archer T.Palomo T, et al.Neurotox Res. 2008 Aug;14(1):1-20. doi: 10.1007/BF03033572.Neurotox Res. 2008.PMID:18790722
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical